The Brigham and Dana-Farber Board Review in Hematology and Oncology 2020 (Videos)

$30.00

Format: 59Video Files (.mp4 format) + 1 PDF File.

Posted By: Dr_magic

0 Rating

published date: 26 Dec 20

Improve Patient Care in Hematology and Oncology

The Brigham and Dana-Farber Board Review in Hematology and Oncology will help improve clinical practice gaps in hematology and oncology derived from the American Board of Internal Medicine (ABIM) certification/recertification requirements. In this CME program, expert speakers address relevant topics in case-based board review presentations. Improve patient care by learning to:

  • Perform differential diagnosis of complex hematologic and oncologic disorders
  • Identify and apply current therapeutic options for hematologic and oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to hematology and oncology
  • Illustrate knowledge of pathophysiology of hematologic and oncologic disorders
  • Apply new knowledge to the ABIM certification/recertification hematology and oncology examinations

Discover New Guidelines

This learn-at-your-own-pace course in hematology and oncology provides a maximum of 44 AMA PRA Category 1 Credits ™ and 44 ABIM MOC points. Available online or via audio MP3 CDs, it provides access to unbiased, evidence-based content and case-based reviews so you can expand your knowledge and incorporate the latest guidelines into your daily practice

 

TOPICS/SPEAKERS

  • Molecular Genetics of Cancer - Nikhil Wagle, MD
  • Advances in Cancer Drug Development - Geoffrey I. Shapiro, MD, PhD
  • Infections in Cancer Patients - Lindsey Baden, MD
  • Symptom Management in Patients with Cancer - Andrew J. Lawton, MD
  • Communication: The Key to Excellence in End-of-Life Care - Rachelle E. Bernacki, MD
  • Biology of Hematopoietic Stem Cell Transplantation - Robert J. Soiffer, MD
  • Biology of Acute Leukemia and Myelodysplastic Syndromes - Benjamin L. Ebert, MD, PhD
  • Acute Leukemias - Daniel J. DeAngelo, MD, PhD
  • Myelodysplastic Syndrome - David P. Steensma, MD
  • Chronic Myelogenous Leukemia - Marlise R. Luskin, MD
  • Myeloproliferative Syndromes - Ann M. Mullally, MD
  • Multiple Myeloma - Kenneth C. Anderson, MD
  • Waldenstrom Macroglobulemia and Amyloidosis - Jorge J. Castillo, MD
  • Low Grade Lymphomas - Caron A. Jacobson, MD
  • High Grade Lymphomas - Eric D. Jacobsen, MD
  • Hodgkin's Lymphoma - Jennifer L. Crombie, MD
  • Diagnosis and Treatment of CLL and Related B Cell Malignancies - Matthew S. Davids, MD
  • Head and Neck Cancer - Robert I. Haddad, MD
  • Natural History, Screening, Surgery and Small Cell Lung Cancer - Bruce E. Johnson, MD
  • Non Small Cell Lung Cancer - Mark Awad, MD, PhD
  • Mesothelioma and Thymoma - David M. Jackman, MD
  • Thyroid Cancer - Jochen Lorch, MD
  • Carcinoid and Pancreatic Neuroendocrine Tumors - Jennifer Ang Chan, MD
  • Esophageal and Gastric Cancer - Peter C. Enzinger, MD
  • Pancreatic and Hepatobiliary Cancer - Brian M. Wolpin, MD
  • Anal Cancers - Robert J. Mayer, MD
  • Colorectal Cancers - Robert J. Mayer, MD
  • Gastrointestinal Cancer: Genetic Syndromes - Matthew Yurgelun, MD
  • Germ Cell Tumor: Maximizing Cure While Minimizing the Burden of Therapy - Mark M. Pomerantz, MD
  • Renal and Bladder Cancer - Guru P. Sonpavde, MBBS
  • Prostate Cancer Part I: Overview and Management of Localized Disease - Atish D. Choudhury, MD, PhD
  • Prostate Cancer Part II: Management of Disseminated Prostate Cancer - Atish D. Choudhury, MD, PhD
  • Melanoma - F. Stephen Hodi, MD
  • Sarcomas and Gastrointestinal Stromal Tumors (GIST) - George D. Demetri, MD
  • Ovarian Cancer - Ursula A. Matulonis, MD
  • Cervical and Endometrial Cancer - Panagiotis A. Konstantinopoulos, MD, PhD
  • Neuro-oncology - David A. Reardon, MD
  • Breast Cancer: Risk Factors, Genetics, Screening, and Prevention - Judy E. Garber, MD, MPH
  • Multimodality Therapy for Early Stage Breast Cancer: Part 1 - Surgery and Radiation - Harold J. Burstein, MD, PhD
  • Multimodality Therapy for Early Stage Breast Cancer: Part 2 - Systemic Therapy - Harold J. Burstein, MD, PhD
  • Management of Metastatic Breast Cancer - Erica Mayer, MD, MPH
  • Breast Cancer Survivorship - Ann H. Partridge, MD, MPH
  • Hematopoiesis and Cytokines - David T. Scadden, MD
  • Acquired Bone Marrow Failure - Julie-Aurore Losman, MD, PhD
  • Congenital Bone Marrow Failure - Akiko Shimamura, MD, PhD
  • Hemophagocytic Syndromes and Related Immunodeficiencies - Barbara A. Degar, MD
  • Anemia: An Overview - Ronald P. McCaffrey, MD
  • Iron Deficiency and Iron Overload - Mark D. Fleming, MD, PhD
  • Immune Hemolytic Anemia - Richard M. Kaufman, MD
  • Non-immune Hemolytic Anemia - David E. Golan, PhD, MD
  • Sickle Cell Disease - Maureen M. Achebe, MD, MPH
  • Thalassemia and Other Hemoglobinopathies - Matthew M. Heeney, MD
  • Disorders of Neutrophils - Nancy Berliner, MD
  • Acquired Thrombocytopenias - Elisabeth M. Battinelli, MD, PhD
  • Hemophilia - Aric D. Parnes, MD
  • Von Willebrand Disease and Congenital Platelet Disorders - Nathan T. Connell, MD, MPH
  • Congenital and Acquired Thrombophilia - Kenneth A. Bauer, MD
  • Use of Direct Oral Anticoagulants in Clinical Practice - Jean M. Connors, MD
  • Transfusion Medicine for the Clinician - Walter H. Dzik, MD

Date of Original Release: April 15, 2020
Termination Date: April 15, 2023